Affiliation:
1. Universite Claude Bernard Lyon-1, CNRS, ISA-UMR 5280, 69100 Villeurbanne, France
2. Department of Stem Cell Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia
3. Biology Department, College of Science, Institute of Research & Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia
Abstract
Worldwide, colon cancer is the third most frequent malignancy and the second most common cause of death. Although it can strike anybody at any age, colon cancer mostly affects the elderly. Small, non-cancerous cell clusters inside the colon, commonly known as polyps, are typically where colon cancer growth starts. But over time, if left untreated, these benign polyps may develop into malignant tissues and develop into colon cancer. For the diagnosis of colon cancer, with routine inspection of the colon region for polyps, several techniques, including colonoscopy and cancer scanning, are used. In the case identifying the polyps in the colon area, efforts are being taken to surgically remove the polyps as quickly as possible before they become malignant. If the polyps become malignant, then colon cancer treatment strategies, such as surgery, chemotherapy, targeted therapy, and immunotherapy, are applied to the patients. Despite the recent improvements in diagnosis and prognosis, the treatment of colorectal cancer (CRC) remains a challenging task. The objective of this review was to discuss how CRC is initiated, and its various developmental stages, pathophysiology, and risk factors, and also to explore the current state of colorectal cancer diagnosis and treatment, as well as recent advancements in the field, such as new screening methods and targeted therapies. We examined the limitations of current methods and discussed the ongoing need for research and development in this area. While this topic may be serious and complex, we hope to engage and inform our audience on this important issue.
Reference89 articles.
1. Olovo, C.V., Huang, X., and Zheng, X. (2021). Faecal microbial biomarkers in early diagnosis of colorectal cancer. J. Cell. Mol. Med.
2. Pavitra, E., Dariya, B., Srivani, G., Kang, S.M., Alam, A., Sudhir, P.R., Kamal, M.A., Raju, G.S.R., Han, Y.K., and Lakkakula, B.V.K.S. (2021). Engineered nanoparticles for imaging and drug delivery in colorectal cancer. Semin. Cancer Biol.
3. (2023, July 30). Data visualization Tools for Exploring the Global Cancer Burden in 2020. Available online: https://gco.iarc.fr/today/.
4. Predictive Value of Circulating Tumor Cells in Prognosis of Stage III/IV Colorectal Cancer after Oxaliplatin-based First-line Chemotherapy;Yu;In Vivo,2022
5. The American Cancer Society Medical and Editorial Content Team (ACSMECT) (2020, June 29). American Cancer Society. Cancer.Org. Available online: https://www.cancer.org/cancer/colon-rectal-cancer/causes-risks-prevention/risk-factors.html.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献